For example, the percentage of CD56+ NK subset in total circulating NK pool was significantly reduced in 21 CML patients (2.5% ± 0.5%) compared with normal donors (5.7% ± 0.8%) (p < 0.001) (181). Here, NCAM1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.